Biomea Fusion, Inc. (BMEA)
$1.85+$0.06 (+3.12%) Latest session
Rainer M. Erdtmann - OfficerRainer M. Erdtmann - OfficerBiomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.
No Form 4 activity for BMEA in the last 90 days.
15 Form 4 filings on record, the earliest from Oct 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Elizabeth Faust | Grant or award | Stock Option (Right to Buy) | 196,299 | $0.00 | - | |
| Eric Aguiar | Grant or award | Stock Option (Right to Buy) | 196,299 | $0.00 | - | |
| Sumita Ray | Grant or award | Stock Option (Right to Buy) | 196,299 | $0.00 | - | |
| Julianne Averill | Grant or award | Stock Option (Right to Buy) | 173,711 | $0.00 | - | |
| Rainer M. Erdtmann - Officer | Grant or award | Stock Option (Right to Buy) | 452,512 | $0.00 | - | |
| Michael J.M. Hitchcock - Officer | Grant or award | Stock Option (Right to Buy) | 667,477 | $0.00 | - | |
| Michael J.M. Hitchcock - Officer | Open-market purchase | Common Stock | 100,000 | $0.99 | $99K | |
| Rainer M. Erdtmann - Officer | Open-market purchase | Common Stock | 10,000 | $1.05 | $11K | |
| Rainer M. Erdtmann - Officer | Open-market purchase | Common Stock | 40,000 | $1.10 | $44K | |
| Rainer M. Erdtmann - Officer | Gift | Common Stock | 40,000 | $0.00 | - | |
| Rainer M. Erdtmann - Officer | Gift | Common Stock | 10,000 | $0.00 | - | |
| Rainer M. Erdtmann - Officer | Gift | Common Stock | 10,000 | $0.00 | - | |
| Rainer M. Erdtmann - Officer | Gift | Common Stock | 10,000 | $0.00 | - | |
| Rainer M. Erdtmann - Officer | Gift | Common Stock | 10,000 | $0.00 | - | |
| Rainer M. Erdtmann - Officer | Gift | Common Stock | 10,000 | $0.00 | - | |
| Rainer M. Erdtmann - Officer | Gift | Common Stock | 10,000 | $0.00 | - | |
| Rainer M. Erdtmann - Officer | Grant or award | Stock Option (Right to Buy) | 1,246,989 | $0.00 | - | |
| Michael J.M. Hitchcock - Officer | Grant or award | Stock Option (Right to Buy) | 916,434 | $0.00 | - | |
| Julianne Averill | Grant or award | Stock Option (Right to Buy) | 241,177 | $0.00 | - | |
| Eric Aguiar | Grant or award | Stock Option (Right to Buy) | 91,970 | $0.00 | - | |
| Franco Valle - Officer | Grant or award | Common Stock | 495 | $6.15 | $3K | |
| Michael J.M. Hitchcock | Open-market purchase | Common Stock | 10,000 | $10.06 | $101K |
Biomea Fusion, Inc. (BMEA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-12. The full record for BMEA runs to 15 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of BMEA were filed in the last 90 days. 4 purchases are on record for this company.
No insider sales of BMEA were filed in the last 90 days.
This page tracks BMEA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BMEA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
